2022 ICD-10-CM Diagnosis Code C50.9: Malignant Neoplasm Of ...
Toggle navigation
Search All ICD-10 Toggle Dropdown
- Search All ICD-10
- ICD-10-CM Diagnosis Codes
- ICD-10-PCS Procedure Codes
- ICD-10-CM Diagnosis Index
- ICD-10-CM External Causes Index
- ICD-10-CM Table of Drugs
- ICD-10-CM Table of Neoplasms
- HCPCS Codes
- ICD-9-CM Diagnosis Codes
- ICD-9-Vol-3 Procedure Code
- Search All Data
2026
- ICD-10-CM Codes ›
- C00-D49 ›
- C50-C50 ›
- C50- ›
- 2026 ICD-10-CM Diagnosis Code C50.9
Malignant neoplasm of breast of unspecified site
- 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Non-Billable/Non-Specific Code
- C50.9 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
- The 2026 edition of ICD-10-CM C50.9 became effective on October 1, 2025.
- This is the American ICD-10-CM version of C50.9 - other international versions of ICD-10 C50.9 may differ.
- Applicable To annotations, or
- Code Also annotations, or
- Code First annotations, or
- Excludes1 annotations, or
- Excludes2 annotations, or
- Includes annotations, or
- Note annotations, or
- Use Additional annotations
- C00-D49 2026 ICD-10-CM Range C00-D49
NeoplasmsNote
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
- C50 ICD-10-CM Diagnosis Code C50
Malignant neoplasm of breast
- 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Non-Billable/Non-Specific Code
- connective tissue of breast
- Paget's disease of breast
- Paget's disease of nipple
- skin of breast (C44.501, C44.511, C44.521, C44.591)
- code to identify estrogen, and other hormones and factors receptor status (Z17.-)
- A primary or metastatic malignant neoplasm involving the breast. The vast majority of cases are carcinomas arising from the breast parenchyma or the nipple. Malignant breast neoplasms occur more frequently in females than in males.
- Breast cancer affects one in eight women during their lives. Breast cancer kills more women in the United States than any cancer except lung cancer. No one knows why some women get breast cancer, but there are a number of risk factors. Risks that you cannot change include
- age - the chance of getting breast cancer rises as a woman gets older
- genes - there are two genes, brca1 and brca2, that greatly increase the risk. Women who have family members with breast or ovarian cancer may wish to be tested.
- personal factors - beginning periods before age 12 or going through menopause after age 55
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- 2024 (effective 10/1/2023): No change
- 2025 (effective 10/1/2024): No change
- 2026 (effective 10/1/2025): No change
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Advertise with Us | License ICD10 Data | Medical billing and coding classes
Copyright © | ICD10data.com
Từ khóa » C50. 9 G R
-
C50.9 Bösartige Neubildung: Brustdrüse, Nicht Näher Bezeichnet
-
ICD-10-Code: C50 Bösartige Neubildung Der Brustdrüse [Mamma]
-
Νόσος ICD-10: C50.9 Διάφορα μέρη του μαστού - Γαληνός
-
Satellite Pro C50D-B-116 - Dynabook
-
Multiple Behaviours In Same Morphology At Same Site - c
-
C50 - ClimbMill | Matrix Fitness - Greece
-
[PDF] ICD-10-CM TABULAR LIST Of DISEASES And INJURIES ... - CMS
-
Water Treatment - Terofox
-
[PDF] ICD-10 C50: Mammakarzinom (Frauen) Inzidenz Und Mortalität
-
Portable Compressors 750 Kg | C35-10 - C50 | CompAir
-
S&R Claw Hammer/Carpenter Hammer ~21oz - 600 Gr, Magnet ...
-
Brustkrebs – Mammakarzinom | DocMedicus Gesundheitslexikon
-
BEPF20-VU5G25-C50-9-Eca PREFLEX Std Grijs 20mm - Rol 50m